How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli

Proceedings of the Society for Experimental Biology and Medicine

Volumn 223, Issue 1, 2000, Pages 22-38

  Rivest, Serge ^a   Lacroix, Steve ^a   Vallières, Luc ^a   Nadeau, Sylvain ^a   Zhang, Ji ^a   Laflamme, Nathalie ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR HYPOTHALAMUS; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN INFECTION; CYTOKINE PRODUCTION; ENDOTOXEMIA; FEVER; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; REVIEW;

ANIMALIA; JANUS; MAMMALIA;

EID: 0034105064     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22304.x     Document Type: Review

References (178)

1. Andersson J, Nagy S, Björk L, Abrams J, Holm S, Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev 127:69-96, 1992.
2. Elmquist JK, Saper CB. Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. J Comp Neurol 374:315-331, 1996.
3. Elmquist JK, Scammell TE, Jacobson CD, Saper CB. Distribution of fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J Comp Neurol 371:85-103, 1996.
4. Laflamme N, Feuvrier E, Richard D, Rivest S. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats. Neuroscience 88:223-240, 1999.
5. Nappi RE, Bonneau MJ, Rivest S. C-fos and CRF gene transcription in the brains of endotoxin-challenged cycling female rats: A possible relevance for neuroendocrine-immunological sexual dimorphism. Neuroendocrinology 65:29-46, 1997.
6. Rivest S, Laflamme N. Neuronal activity and neuropeptide gene transcription in the brain of immune-challenged rats. J Neuroendocrinol 7:501-525, 1995.
7. Rivest S, Laflamme N, Nappi RE. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 15:2680-2695, 1995.
8. Berkenbosch F, Oers JV, Rey AD, Tilders F, Besedovsky H. Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science 238:524-526, 1987.
9. Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gomez MT, Gold PW, Chrousos GP. Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126:2876-2881, 1990.
10. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524, 1987.
11. Sharp BM, Matta SG, Peterson PK, Newton R, Chao C, McAllen K. Tumor necrosis factor-α is a potent ACTH secretagogue: Comparison to interleukin-1β. Endocrinology 124:3131-3133, 1989.
12. Tsagarakis S, Gillies G, Rees LH, Besser M, Grossman A. Interleukin-1 directly stimulates the release of corticotrophin-releasing factor from rat hypothalamus. Neuroendocrinology 49:98-101, 1989.
13. Watanobe H, Takebe K. Intravenous administration of tumor necrosis factor-α stimulates corticotropin-releasing hormone secretion in the push-pull cannulated median eminence of freely moving rats. Neuropeptides 22:81-84, 1992.
14. Givalois L, Dornand J, Mekaouche M, Solier MD, Bristow AF, Ixart G, Siaud P, Assenmacher I, Barbanel G. The temporal cascade of plasma level surges in ACTH, corticosterone and cytokines in endotoxin-challenged rats. Am J Physiol 266:R164-R170, 1994.
15. Dunn AJ. The role of interleukin-1 and tumor necrosis factor-α in the neurochemical and neuroendocrine responses to endotoxin. Brain Res Bull 6:807-812, 1992.
16. Kakucska I, Qi Y, Clark BD, Lechan RM. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133:815-821, 1993.
17. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132:946-952, 1993.
18. Fantuzzi G, Dinarello CA. The inflammatory response in interleukin-1β-deficient mice: Comparison with other cytokine-related knockout mice. J Leukoc Biol 59:489-493, 1996.
19. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433, 1990.
20. Lacroix S, Feinstein D, Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol 8:625-640, 1998.
21. Nadeau S, Rivest S. Regulation of the gene encoding tumor necrosis factor-α in the rat brain and pituitary in response to different models of systemic immune challenge. J Neuropathol Exp Neurol 58:61-77, 1999.
22. Quan N, Whiteside M, Herkenham M. Time course and localization patterns of interleukin-1β mRNA expression in the brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83:281-293, 1997.
23. Vallières L, Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β. J Neurochem 69:1668-1683, 1997.
24. Oldfield BJ, Mckinley MJ. Circumventricular organs. In: Paxinos G, Ed. The Rat Nervous System. San Diego: Academic Press, pp391-403, 1995.
25. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expression in vivo: Extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 181:857-866, 1995.
26. Beg AA, Finco TS, Nantermet PV, Baldwin AS. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: A mechanism for NF-κB activation. Mol Cell Biol 13:3301-3310, 1993.
27. Fearns C, Loskutoff DJ. Role of tumor necrosis factor-α in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 65:4822-4831, 1997.
28. Fearns C, Ulevitch RJ. Effect of recombinant interleukin-1β on murine CD14 gene expression in vivo. Shock 9:157-163, 1998.
29. Wright SD. Toll, a new piece in the puzzle of innate immunity. J Exp Med 189:605-609, 1999.
30. Baeuerle PA. Pro-inflammatory signaling: Last pieces in the NF-κB puzzle. Curr Biol 8:R19-R22, 1998.
31. Baeuerle PA, Baltimore D. NF-κB: Ten years after. Cell 87:13-20, 1996.
32. Laflamme N, Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor-κBα within specific cellular populations of the rat brain. J Neurochem 73:309-321, 1999.
33. Quan N, Whiteside M, Kim L, Herkenham M. Induction of inhibitory factor κBα mRNA in the central nervous system after peripheral lipopolysaccharide administration: An in situ hybridzation histochemistry study in the rat. Proc Natl Acad Sci U S A 94:10985-10990, 1997.
34. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 40:226-236, 1997.
35. Sorli CH, Zhang HJ, Armstrong MB, Rajotte RV, MacIouf J, Robertson RP. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A 95:1788-1793, 1998.
36. Inoue H, Tanabe T. Transcriptional role of the nuclear factor κB site in the induction by liopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 244:143-148, 1998.
37. Schmedtje JF Jr., Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272:601-608, 1997.
38. Lacroix S, Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 70:452-466, 1998.
39. Arditi M, Zhou J, Torres M, Durden DL, Stins M, Kim KS. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner: Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J Immunol 155:3994-4003, 1995.
40. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Soszynski D, Grabiec C, Trumbauer ME, Shaw A, Kostura MJ, Stevens K, Rosen H, North RJ, Chen HY, Tocci MJ, Kluger MJ, VanDerPloeg LHT. Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice. Immunity 3:9-19, 1995.
41. Barbanel G, Ixart G, Szafarczyk A, Malaval F, Assenmacher I. Intrahypothalamic infusion of interleukin-1β increases the release of corticotropin-releasing hormone (CRH 41) and adrenocorticotropic hormone (ACTH) in free-moving rats bearing a push-pull cannula in the median eminence. Brain Res 516:31-36, 1990.
42. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Interleukin-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128:37-44, 1991.
43. Rivest S, Torres G, Rivier C. Differential effects of central and peripheral injection of interleukin-1β on brain c-fos expression and neuroendocrine functions. Brain Res 587:13-23, 1992.
44. Suda T, Tozawa F, Ushiyama T, Sumitomo T, Yamada M, Demura H. Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126:1223-1228, 1990.
45. Orth DN, Kovacs WJ, DeBold CR. The adrenal cortex. In: Wilson JD, Foster DW, Eds. Textbook of Endocrinology. Philadelphia: W.B. Saunders, pp489-619, 1992.
46. Edwards CK, Yunger LM, Lorence RM, Dantzer R, Kelley KW. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci U S A 88:2274-2277, 1991.
47. Mason D, MacPhee I, Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis. Immunology 70:1-5, 1990.
48. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A 86:2374-2378, 1989.
49. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of I-κB synthesis. Science 270:286-290, 1995.
50. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I-κBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286, 1995.
51. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94:13504-13509, 1997.
52. Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol Endocrinol 12:355-363, 1998.
53. Blalock J, Smith EM. A complete loop between the immune system and neuroendocrine systems. Fed Proc 44:108-111, 1985.
54. Koenig JI. Presence of cytokines in the hypothalamic-pituitary axis. Prog Neuro Endocr Immunol 4:143-153, 1991.
55. Rivest S. Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. Int J Dev Neurosci 13:135-146, 1995.
56. Rivest S, Rivier C. The role of CRF and interleukin-1 in the regulation of neurons controlling reproductive functions. Endocr Rev 16:177-199, 1995.
57. Rivier C, Rivest S. Mechanisms mediating the effects of cytokines in neuroendocrine functions in the rat. In: Chadwick DJ, Marsh J, Ackrill K, Eds. Corticotropin-Releasing Factor, Ciba Foundation Symposium 172. Chichester: John Wiley & Sons Ltd, pp204-225, 1993.
58. Besedovsky HO, DelRey A. Immune-neuro-endocrine interacts: Facts and hypotheses. Endocr Rev 17:64-102, 1996.
59. Schöbitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6, and tumor necrosis factor in the brain. Prog Neurobiol 44:397-432, 1994.
60. Rivest S, Rivier C. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin. Endocrinology 129:2049-2057, 1991.
61. Uehara A, Gotschall PE, Dahl RR, Arimura A. Interleukin-1 stimulates ACTH release by an indirect mechanism which requires endogenous corticotropin-releasing factor. Endocrinology 121:1580-1587, 1937.
62. Ericsson A, Kovács KJ, Sawchenko PE. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14:897-913, 1994.
63. Rivest S, Rivier C. Stress and interleukin-1β-induced activation of c-fos, NGFI-B, and CRF gene expression in the hypothalamic PVN: Comparison between Sprague-Dawley, Fisher-344, and Lewis rats. J Neuroendocrinol 6:101-117, 1994.
64. Brady L, Lynn AB, Herkenham M, Gottesfeld Z, Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 14:4951-4964, 1994.
65. Ericsson A, Liu C, Hart RP, Sawchenko PE. Type-1 interleukin-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361:681-698, 1995.
66. Laflamme N, Lacroix S, Rivest S. An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci, in press, 1999.
67. Elmquist JK, Breder CD, Sherin JE, Scammell TE, Hickey WF, Dewitt D, Saper CB. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J Comp Neurol 381:119-129, 1997.
68. Cao C, Matsumura K, Ozaki M, Watanabe Y. Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells. J Neurosci 19:716-725, 1999.
69. Matsumura K, Cao C, Ozaki M, Morii H, Nakadate K, Watanabe Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: Light and electron microscopic immunocytochemical studies. J Neurosci 18:6279-6289, 1998.
70. Quan N, Whiteside M, Herkenham M. Cyclooxygenase-2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res 802:189-197, 1998.
71. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187:1463-1475, 1998.
72. Cao C, Matsumura K, Yamagata K, Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: A possible site of prostaglandin synthesis responsible for fever. Brain Res 733:263-272, 1996.
73. Cao CY, Matsumura K, Yamagata K, Watanabe Y. Endothelial cells of the rat-brain vasculature express cyclooxygenase-2 messenger-RNA in response to systemic interleukin-1: A possible site of prostaglandin synthesis responsible for fever. Brain Res 733:263-272, 1996.
74. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72:3666-3670, 1975.
75. Miller VE, Rogers K, Muirden KD. Detection of tumour necrosis factor-α and interleukin-1β in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods. Rheumatol Int 13:77-82, 1993.
76. Goldfeld AE, Strominger JL, Doyle C. Human tumor necrosis factor-α gene regulation in phorbol ester-stimulated T and B cell lines. J Exp Med 174:73-81, 1991.
77. Chung IY, Benveniste EN. Tumor necrosis factor-α production by astrocytes: Induction by lipopolysaccharide, IFN-γ, and IL-1β. J Immunol 144:2999-3007, 1990.
78. Wilkinson LS, Edwards JC. Binding of antibodies raised against tumour necrosis factor-α (TNF-α) to blood vessels and macrophages in inflamed synovial tissue. Rheumatol Int 11:19-25, 1991.
79. Brennan FNI, Maini RN, Feldmann M. TNF-α: A pivotal role in rheumatoid arthritis? Br J Rheumatol 31:293-298, 1992.
80. Liu L, Kita T, Tanaka N, Kinoshita Y. The expression of tumour necrosis factor in the hypothalamus after treatment with lipopolysaccharide. Int J Exp Pathol 77:37-44, 1996.
81. Breder CD, Hazuka C, Ghayur T, Klug C, Huginin M, Yasuda K, Teng M, Saper CB. Regional induction of tumor necrosis factor-α expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci U S A 22:11393-11397, 1994.
82. Turnbull AV, Pitossi FJ, Lebrun J-J, Lee S, Meltzer JC, Nance DM, del Rey A, Besedovsky HO, Rivier C. Inhibition of tumor necrosis factor-α action within the CNS markedly reduces the plasma adrenocorticotropin response to peripheral local inflammation. J Neurosci 17:3262-3273, 1997.
83. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin-β and interleukin-6 appearance during lethal bacteremia. J Exp Med 170:1627-1633, 1989.
84. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A 94:8093-8098, 1997.
85. Nadeau S, Rivest S. Effects of circulating tumor necrosis factor (TNF) on the neuronal activity and expression of the genes encoding the TNF receptors (p55 and p75) in the rat brain: A view from the blood brain barrier. Neuroscience 93:1449-1464, 1999.
86. Milenkovic L, Rettori V, Snyder GD, Beutler B, McCann SM. Cachectin alters anterior pituitary hormone release by a direct action in vitro. Proc Natl Acad Sci U S A 86:2418-2422, 1989.
87. Kovacs KJ, Elenkov IJ. Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. J Neuroendocrinol 7:15-23, 1995.
88. VanderMeer MJ, Hermus AR, Pesman GJ, Sweep CG. Effects of cytokines on pituitary β-endorphin and adrenal corticosterone release in vitro. Cytokine 8:238-247, 1996.
89. Ebisui O, Fukata J, Murakami N, Kobayashi H, Segawa H, Muro S, Hanaoka I, Naito Y, Masui Y, Ohmoto Y, et al. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am J Physiol 266:E986-E992, 1994.
90. Turnbull AV, Rivier CL. Intracerebroventricular passive immunization. I. The effect of intracerebroventricular administration of an antiserum to tumor necrosis factor-α on the plasma adrenocorticotropin response to lipopolysaccharide in rats. Endocrinology 139:119-127, 1998.
91. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-581, 1989.
92. Taga T. The signal transducer gp130 is shared by the interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 29:63-72, 1997.
93. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819, 1997.
94. Lütticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T, et al. Association of transcription factor APRF and protein kinase Jak1 with the interleuldn-6 signal transducer gp130. Science 263:89-92, 1994.
95. Narazaki M, Witthuhn BA, Yoshida K, Silvennoinen O, Yasukawa K, Ihle JN, Kishimoto T, Taga T. Activation of JAK2 kinase mediated by the interleukin-6 signal transducer gp130. Proc Natl Acad Sci U S A 91:2285-2289, 1994.
96. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr., Yancopoufos GD. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349-1353, 1995.
97. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71, 1994.
98. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5:449-460, 1996.
99. Sadowski HB, Shuai K, Darnell JE Jr., Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739-1744, 1993.
100. Zhong Z, Wen Z, Darnell JE Jr. Stat3 and Stat4: Members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci U S A 91:4806-4810, 1994.
101. Zhong Z, Wen Z, Darnell JE Jr. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98, 1994.
102. Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578-1588, 1996.
103. Watanabe S, Arai K. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr Opin Genet Dev 6:587-596, 1996.
104. Boulton TG, Stahl N, Yancopoulos GD. Ciliary neurotrophic factor/ leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J Biol Chem 269:11648-11655, 1994.
105. Daeipour M, Kumar G, Amaral MC, Nel AE. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. J Immunol 150:4743-4753, 1993.
106. Kumar G, Gupta S, Wang S, Nel AE. Involvement of Janus kinases, p52shc, raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line. J Immunol 153:4436-4447, 1994.
107. Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC. IL-6 triggers cell growth via the ras-dependent mitogen-activated protein kinase cascade. J Immunol 159:2212-2221, 1997.
108. Takahashi-Tezuka M, Yoshida Y, Fukada T, Ohtani T, Yamanaka Y, Nishida K, Nakajima K, Hibi M, Hirano T. Gabi acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell Biol 18:4109-4117, 1998.
109. Ernst M, Gearing DP, Dunn AR. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J 13:1574-1584, 1994.
110. Giordano V, De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, Delmastro P, Gadina M, Scala G. She mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J Immunol 158:4097-4103, 1997.
111. Matsuda T, Takahashi-Tezuka M, Fukada T, Okuyama Y, Fujitani Y, Tsukada S, Mano H, Hirai H, Witte ON, Hirano T. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85:627-633, 1995.
112. Neumann C, Zehentmaier G, Danhauser-Riedl S, Emmerich B, Hallek M. Interleukin-6 induces tyrosine phosphorylation of the Ras-activating protein She, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1. Eur J Immunol 26:379-384, 1996.
113. Qiu Y, Ravi L, Kung HJ. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature 393:83-85, 1998.
114. Nesbitt JE, Fuller GM. Dynamics of interleukin-6 internalization and degradation in rat hepatocytes. J Biol Chem 267:5739-5742, 1992.
115. Rose-John S, Hipp E, Lenz D, Legres LG, Korr H, Hirano T, Kishimoto T, Heinrich PC. Structural and functional studies on the human interleukin-6 receptor: Binding, cross-linking, internalization, and degradation of interleukin-6 by fibroblasts transfected with human interleukin-6-receptor cDNA. J Biol Chem 266:3841-3846, 1991.
116. Zohlnhofer D, Graeve L, Rose-John S, Schooltink H, Dittrich E, Heinrich PC. The hepatic interleukin-6 receptor: Downregulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett 306:219-222, 1992.
117. Thiel S, Behrmann I, Dittrich E, Muys L, Tavernier J, Wijdenes J, Heinrich PC, Graeve L. Internalization of the interleukin-6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem J 330:47-54, 1998.
118. Aman MJ, Leonard WJ. Cytokine signaling: Cytokine-inducible signaling inhibitors. Curr Biol 7:R784-R788, 1997.
119. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci US A 95:114-119, 1998.
120. Nicholson SE, Hilton DJ. The SOCS proteins: A new family of negative regulators of signal transduction. J Leukoc Biol 63:665-668, 1998.
121. Auernhammer CJ, Chesnokova V, Bousquet C, Melmed S. Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediate proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol Endocrinol 12:954-961, 1998.
122. Poupart P, Vandenabeele P, Cayphas S, Vansnick J, Haegeman G, Kruys V, Fiers W, Content J. B-cell growth modulating and differentiating activity of recombinant human 26-kDa protein (BSF-2, HuIFN-β2, HPGF). EMBO J 6:1219-1224, 1987.
123. Conti P, Bartle L, Barbacane RC, Reale M, Placido FC, Sipe J. Synergistic activation of serum amyloid A (SAA) by IL-6 and IL-1 in combination on human Hep 3B hepatoma cell line: Role of PGE2 and IL-1 receptor antagonist. Immunol Invest 24:523-535, 1995.
124. Tritarelli E, Greco G, Testa U, Belardelli F, Peschle C, Proietti E. Combined interleukin-1β/interleukin-6 treatment in mice: Synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression. Cancer Res 54:6469-6476, 1994.
125. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL-1 and TNF). FASEB J 4:2860-2867, 1990.
126. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. Interleukin(IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: A study on IL-6-deficient mice. J Exp Med 183:311-316, 1996.
127. Dinarello CA, Cannon JG, Mancilla J, Bishai I, Lees J, Coceani F. Interleukin-6 as an endogenous pyrogen: Induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res 562:199-206, 1991.
128. Fernandez-Alonso A, Benamar K, Sancibrian M, Lopez-Valpuesta FJ, Minano FJ. Role of interleukin-1β, interleukin-6, and macrophage inflammatory protein-1β in prostaglandin-E2-induced hyperthermia in rats. Life Sci 59:L185-L190, 1996.
129. Xin L, Blatteis CM. Blockade by interleukin-1 receptor antagonist of IL-1β-induced neuronal activity in guinea pig preoptic area slices. Brain Res 569:348-352, 1992.
130. Lyson K, McCann SM. Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology 55:708-713, 1992.
131. Bishai I, Coceani F. Differential effects of endotoxin and cytokines on prostaglandin E2 formation in cerebral microvessels and brain parenchyma: Implications for the pathogenesis of fever. Cytokine 8:371-376, 1996.
132. Bauer MK, Lieb K, Schulze-Osthoff K, Berger M, Gebicke-Haerter PJ, Bauer J, Fiebich BL. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 243:726-731, 1997.
133. Hinson RM, Williams JA, Shacter E. Elevated interleukin-6 is induced by prostaglandin E2 in a murine model of inflammation: Possible role of cyclooxygenase-2. Proc Natl Acad Sci U S A 93:4885-4890, 1996.
134. Williams JA, Shacter E. Regulation of macrophage cytokine production by prostaglandin E2: Distinct roles of cyclooxygenase-1 and -2. J Biol Chem 272:25693-25699, 1997.
135. Fiebich BL, Hull M, Lieb K, Gyufko K, Berger M, Bauer J. Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J Neurochem 68:704-709, 1997.
136. Fukata J, Usui T, Naitoh Y, Nakay y Imura H. Effects of recombinant human interleukin-1α, -1β, 2, and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 122:33-39, 1989.
137. Lyson K, McCann SM. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 54:262-266, 1991.
138. Path G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: Expression and effects on steroidogenesis. J Clin Endocrinol Metab 82:2343-2349, 1997.
139. Salas MA, Evans SW, Levell MJ, Whicher JT. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol 79:470-473, 1990.
140. Weber MM, Michl P, Auernhammer CJ, Engelhardt D. Interleukin-3 and interleukin-6 stimulate Cortisol secretion from adult human adrenocortical cells. Endocrinology 138:2207-2210, 1997.
141. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Sunao T, Kenjiro M, Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 155:1459-1463, 1988.
142. Harbuz MS, Stephanou A, Sarlis N, Lightman SL. The effects of recombinant human interleukin (IL)-1α, IL-1β, or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol 133:349-355, 1992.
143. Valliéres L, Lacroix S, Rivest S. Influence of interleukin-6 on neural activity and transcription of the gene encoding corticotropin-releasing factor in the rat brain: An effect depending upon the route of administration. Eur J Neurosci 9:1461-1472, 1997.
144. Valliéres L, Rivest S. Interleukin-6 is a needed proinflamamtory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140:3890-3903, 1999.
145. Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. Characterization of early cytokine responses and an interleukin(IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 185:1185-1192, 1997.
146. Neta R, Perlstein R, Vogel SN, Ledney GD, Abrams J. Role of interleukin-6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med 175:689-694, 1992.
147. McCoy JG, Matta SG, Sharp BM. Prostaglandins mediate the ACTH response to interleukin-1-β instilled into the hypothalamic median eminence. Neuroendocrinology 60:426-435, 1994.
148. Katsuura G, Gottschall PE, Dahl RR, Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: Possible involvement of prostaglandin. Endocrinology 122:1773-1779, 1988.
149. Rivier C. Neuroendocrine effects of cytokines in the rat. Rev Neurosci 4:223-237, 1993.
150. Sharp BM, Matta SG. Prostaglandins mediate the adrenocorticotropin response to tumor necrosis factor in rats. Endocrinology 132:269-274, 1993.
151. Rivest S, Rivier C. Centrally injected interleukin-1β inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in
152. Yasin SA, Costa A, Forsling ML, Grossman A. Interleukin-1β and interleukin-6 stimulate neurohypophysial hormone release in vitro. J Neuroendocrinol 6:179-184, 1994.
153. Lacroix S, Rivest S. Functional circuitry in the brain of immune-challenged rats: Partial involvement of prostaglandins. J Comp Neurol 387:307-324, 1997.
154. Lacroix S, Rivest S. Role of cyclooxygenase pathways in the stimulatory influence of immune challenge in the transcription of a specific CRF receptor subtype in the rat brain. J Chem Neuroanat 10:53-71, 1996.
155. Navarra P, Pozzoli G, Brunetti L, Ragazzoni E, Besser M, Grossman A. Interleukin-1β and interleukin-6 specifically increase the release of prostaglandin E2 from rat hypothalamic explants in vitro. Neuroendocrinology 56:61-68, 1992.
156. Komaki G, Arimura A, Koves K. Effect of intravenous injection of IL-1β on PGE2 levels in several brain areas as determined by microdialysis. Am J Physiol 262:E246-E251, 1992.
157. Katsuura G, Gottschall PE, Dahl RR, Arimura A. Interleukin-1β increases prostaglandin E2 in rat astrocyte cultures: Modulating effect of neuropeptides. Endocrinology 124:3125-3127, 1989.
158. Hughes JH, Easom RA, Wolf BA, Turk J, McDaniel ML. Interleukin-1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Diabetes 38:1251-1257, 1989.
159. Kohan DE. Interleukin-1 regulation of prostaglandin E2 synthesis by the papillary collecting duct. J Lab Clin Med 114:717-723, 1989.
160. Matsumura K, Watanabe Y, Imai-Matsumura K, Connolly M, Koyama Y, Onoe H, Watanabe Y. Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography. Brain Res 581:292-298, 1992.
161. Matsumura K, Watanabe Y, Onoe H, Watanabe Y, Hayaishi O. High density of prostaglandin E2 binding sites in the anterior wall of the 3rd ventricle: A possible site of its hyperthermic action. Brain Res 533:147-151, 1990.
162. Rassnick S, Zhou DH, Rabin BS. Central administration of prostaglandin E2 suppresses in vitro cellular immune responses. Am J Physiol 269:R92-R97, 1995.
163. Katsuura G, Arimura A, Koves K, Gottschall PE. Involvement of organum vasculosum of the lamina terminalis and preoptic area in interleukin-1β-induced ACTH release. Am J Physiol 258:E163-E171, 1990.
164. Ando T, Ichijo T, Katafuchi T, Hori T. Intracerebroventricular injection of prostaglandin E2 increases splenic sympathetic nerve activity in rats. Am J Physiol 269:R662-R668, 1995.
165. Feuerstein G, Adelberg SA, Kopin IJ, Jacubowitz DM. Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2. Brain Res 231:335-342, 1982.
166. Oka T, Hori T. EP1-receptor mediation of prostaglandin E2-induced hyperthermia in rats. Am J Physiol 267:R289-R294, 1994.
167. Lacroix S, Vallières L, Rivest S. C-fos mRNA pattern and CRF neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J Neuroimmunol 70:163-179, 1996.
168. Scammell TE, Elmquist JK, Griffin JD, Saper CB. Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways. J Neurosci 16:6246-6254, 1996.
169. Cao C, Matsumura K, Yamagata K, Watanabe Y. Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factor. Brain Res Mol Brain Res 56:45-56, 1998.
170. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229, 1994.
171. Nishigaki N, Negishi M, Honda A, Sugimoto Y, Namba T, Narumiya S, Ichikawa A. Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells as EP4 subtype. FEBS Lett 364:339-341, 1995.
172. Ericsson A, Ek M, Lindefors N. Distribution of prostaglandins E2 receptor (EP3 subtype) mRNA containing cells in the rat central nervous system. Soc Neurosci Abstr 21:98, 1995.
173. Matsumura K, Cao C, Watanabe Y. Prostaglandin system in the brain: Sites of biosynthesis and sites of action under normal and hyperthermic states. Prog Brain Res 115:275-295, 1998.
174. Hosoi M, Oka T, Hori T. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats. Pain 71:303-311, 1997.
175. Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, Narumiya S. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395:281-284, 1998.
176. Zhang J, Rivest S. Distribution, regulation, and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci 11:2651-2668, 1999.
177. Herkenham M, Lee HY, Baker R. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: A cascade of non-neuronal cellular activation at the blood-brain barrier. J Comp Neurol 400:175-196, 1998.
178. Elmquist JK, Scammell TE, Saper CB. Mechanisms of CNS response to systemic immune challenge: The febrile response. Trends Neurosci 20:565-570, 1997.